Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:45AM ET
25.44
Dollar change
+0.32
Percentage change
1.29
%
IndexRUT P/E- EPS (ttm)-4.03 Insider Own21.47% Shs Outstand46.72M Perf Week-2.28%
Market Cap1.19B Forward P/E40.83 EPS next Y0.62 Insider Trans-0.31% Shs Float36.60M Perf Month-11.92%
Income-160.91M PEG- EPS next Q-0.36 Inst Own91.35% Short Float22.23% Perf Quarter-15.35%
Sales186.37M P/S6.36 EPS this Y75.39% Inst Trans11.41% Short Ratio13.58 Perf Half Y-17.39%
Book/sh5.32 P/B4.78 EPS next Y164.27% ROA-32.20% Short Interest8.14M Perf Year11.16%
Cash/sh6.14 P/C4.14 EPS next 5Y- ROE-82.37% 52W Range21.83 - 35.56 Perf YTD-13.80%
Dividend Est.- P/FCF- EPS past 5Y-39.57% ROI-28.95% 52W High-28.44% Beta1.14
Dividend TTM- Quick Ratio4.19 Sales past 5Y88.90% Gross Margin75.98% 52W Low16.53% ATR (14)1.20
Dividend Ex-Date- Current Ratio4.45 EPS Y/Y TTM-0.28% Oper. Margin-57.22% RSI (14)39.02 Volatility4.25% 4.80%
Employees264 Debt/Eq1.24 Sales Y/Y TTM141.85% Profit Margin-86.33% Recom1.11 Target Price50.78
Option/ShortYes / Yes LT Debt/Eq1.23 EPS Q/Q28.44% Payout- Rel Volume0.28 Prev Close25.12
Sales Surprise2.49% EPS Surprise-162.39% Sales Q/Q149.24% EarningsFeb 28 AMC Avg Volume599.15K Price25.44
SMA20-6.61% SMA50-7.16% SMA200-10.20% Trades Volume63,155 Change1.29%
Date Action Analyst Rating Change Price Target Change
Dec-18-23Reiterated H.C. Wainwright Buy $60 → $58
Nov-20-23Resumed JP Morgan Overweight $37
Nov-13-23Initiated Morgan Stanley Overweight $60
Oct-24-23Initiated Cantor Fitzgerald Overweight $50
Oct-17-23Resumed Evercore ISI Outperform $62
Sep-20-23Initiated JMP Securities Mkt Outperform $70
Sep-01-22Initiated Citigroup Buy $38
Sep-20-21Initiated JP Morgan Overweight $30
Aug-07-20Upgrade Raymond James Outperform → Strong Buy $28 → $48
Aug-03-20Initiated H.C. Wainwright Buy $52
Mar-25-24 11:46PM
07:00AM
Mar-15-24 09:32AM
Mar-13-24 06:00PM
Mar-08-24 07:30PM
08:00AM Loading…
Mar-05-24 08:00AM
Feb-29-24 11:34AM
09:49AM
08:30AM
Feb-28-24 05:35PM
04:38PM
04:03PM
Feb-21-24 04:05PM
Feb-09-24 09:15PM
Feb-05-24 07:00AM
11:44AM Loading…
Jan-23-24 11:44AM
Jan-19-24 09:30PM
Jan-16-24 08:30AM
Jan-15-24 04:03AM
Jan-10-24 07:00PM
Jan-08-24 08:30AM
Jan-03-24 08:45AM
Dec-18-23 01:05PM
08:37AM
08:30AM
Dec-08-23 07:30PM
Nov-30-23 09:45AM
Nov-20-23 04:05PM
Nov-13-23 02:00PM
Nov-10-23 05:30PM
09:10AM Loading…
Nov-06-23 09:10AM
Nov-03-23 08:30AM
Nov-02-23 07:13PM
04:05PM
Oct-30-23 10:00AM
08:30AM
Oct-27-23 08:45AM
Oct-17-23 04:30PM
Oct-11-23 04:52PM
Oct-10-23 08:00PM
Oct-07-23 05:00PM
Oct-02-23 08:30AM
Sep-26-23 08:30AM
Sep-21-23 08:30AM
Sep-15-23 03:05PM
08:30AM
06:01AM
Sep-14-23 01:15PM
Sep-13-23 01:01PM
Sep-11-23 10:07AM
Sep-08-23 11:30PM
Sep-06-23 11:19AM
08:30AM
Sep-05-23 08:30AM
08:30AM
Aug-10-23 07:00PM
Aug-03-23 05:25PM
04:05PM
Jul-27-23 04:05PM
Jul-25-23 05:12PM
08:30AM
Jul-20-23 08:18AM
Jul-18-23 10:48AM
Jul-17-23 02:18PM
08:00AM
08:00AM
Jul-10-23 08:00PM
Jun-29-23 09:27AM
Jun-23-23 12:00PM
Jun-14-23 08:30AM
Jun-09-23 09:30PM
Jun-07-23 08:30AM
Jun-02-23 08:49AM
May-19-23 07:00AM
May-18-23 08:30AM
May-17-23 08:30AM
May-11-23 08:30AM
May-10-23 09:00PM
May-09-23 02:59PM
May-06-23 08:05AM
May-04-23 06:05PM
04:02PM
May-01-23 10:00AM
Apr-27-23 04:02PM
10:02AM
Apr-25-23 05:44AM
Apr-18-23 06:15AM
Apr-13-23 12:15AM
Apr-12-23 07:00AM
06:59AM
Apr-10-23 08:30PM
Apr-06-23 08:30AM
Apr-05-23 08:30AM
Apr-02-23 11:36AM
Mar-31-23 06:39AM
Mar-15-23 09:05AM
Mar-14-23 08:30AM
Mar-11-23 06:40AM
Mar-10-23 08:30PM
Mar-09-23 12:27PM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 27 '24Buy24.802,00049,60014,000Mar 27 08:47 PM
Radovich PeterPRESIDENT AND COOMar 25 '24Sale25.804,303111,01729,013Mar 25 05:41 PM
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 18 '24Buy25.802,00051,60012,000Mar 18 05:34 PM
Peetz ChristopherCHIEF EXECUTIVE OFFICERFeb 02 '24Sale26.196,013157,491104,112Feb 05 09:04 PM
Radovich PeterPRESIDENT AND COOFeb 02 '24Sale26.191,79046,88334,695Feb 05 09:05 PM
Vig PamelaCHIEF SCIENTIFIC OFFICERFeb 02 '24Sale26.191,21431,79728,691Feb 05 09:12 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERFeb 02 '24Sale26.1984722,184104,407Feb 05 09:10 PM
Howe JolandaSVP, GLOBAL CONTROLLERFeb 02 '24Sale26.1973519,2511,759Feb 02 09:28 PM
Peetz ChristopherPRESIDENT AND CEOJan 08 '24Sale28.035,209146,033110,125Jan 09 08:12 PM
Radovich PeterCHIEF OPERATING OFFICERJan 08 '24Sale28.031,40839,47336,485Jan 09 08:28 PM
Vig PamelaHEAD OF RESEARCH & DEVELOPMENTJan 08 '24Sale28.031,40839,47229,905Jan 09 08:21 PM
Longpre LaraCHIEF DEVELOPMENT OFFICERJan 08 '24Sale28.041,01928,568105,254Jan 09 08:25 PM
Howe JolandaSVP, GLOBAL CONTROLLERJan 08 '24Sale28.0452814,803722Jan 09 08:09 PM
Howe JolandaSVP, Global ControllerDec 05 '23Option Exercise2.942,5007,3502,500Dec 06 05:16 PM
Howe JolandaSVP, Global ControllerDec 05 '23Sale32.402,50081,0000Dec 06 05:16 PM
GREY MICHAEL GDirectorSep 14 '23Option Exercise2.9414,21641,73814,216Sep 14 07:33 PM
GREY MICHAEL GDirectorSep 14 '23Sale32.0014,216454,9120Sep 14 07:33 PM
GREY MICHAEL GDirectorSep 13 '23Option Exercise2.943921,151392Sep 14 07:33 PM
Heron Patrick JDirectorSep 13 '23Buy31.022,62581,425159,053Sep 15 04:56 PM
GREY MICHAEL GDirectorSep 13 '23Sale32.0039212,5440Sep 14 07:33 PM
Heron Patrick JDirectorSep 12 '23Buy30.603,750114,764156,428Sep 13 04:39 PM
BJERKHOLT ERICChief Financial OfficerSep 11 '23Buy29.6510,000296,49210,000Sep 12 06:23 PM
Heron Patrick JDirectorSep 11 '23Buy30.304,687142,027152,678Sep 13 04:39 PM
Heron Patrick JDirectorAug 31 '23Buy26.25147,9913,884,764147,991Sep 05 12:51 PM
Howe JolandaSVP, Global ControllerAug 25 '23Sale26.233,45990,7430Aug 28 04:30 PM
Peetz ChristopherPresident and CEOJul 03 '23Sale25.655,498141,005115,334Jul 05 07:30 PM
Radovich PeterChief Operating OfficerJul 03 '23Sale25.651,42536,54637,675Jul 05 07:47 PM
Vig PamelaHead of Research & DevelopmentJul 03 '23Sale25.651,42536,54630,786Jul 05 07:35 PM
Longpre LaraChief Development OfficerJul 03 '23Sale25.651,00425,749105,839Jul 05 07:37 PM
Howe JolandaSVP, Global ControllerJul 03 '23Sale25.6591523,4673,459Jul 05 07:33 PM
GREY MICHAEL GDirectorJun 08 '23Option Exercise2.9414,60842,88914,608Jun 09 04:20 PM
GREY MICHAEL GDirectorJun 08 '23Sale29.0014,608423,6320Jun 09 04:20 PM
GREY MICHAEL GDirectorMay 03 '23Option Exercise2.9414,60842,88914,608May 04 09:58 PM
GREY MICHAEL GDirectorMay 03 '23Sale28.0014,608409,0240May 04 09:58 PM